|Bid||16.02 x 1000|
|Ask||17.32 x 900|
|Day's Range||16.26 - 17.21|
|52 Week Range||15.16 - 28.06|
|Beta (5Y Monthly)||0.52|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 22, 2022 - Feb 28, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||28.89|
With the business potentially at an important milestone, we thought we'd take a closer look at ACADIA Pharmaceuticals...
Acadia (ACAD) posts wider-than-expected loss for the first quarter of 2022 while revenues miss estimates.
Acadia (ACAD) delivered earnings and revenue surprises of -42.86% and 6.68%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?